Legal
EVLV
The Schall Law Firm has announced a class action lawsuit against Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) for alleged securities fraud. Investors who purchased EVLV securities between August 19, 2022, and October 30, 2024, are encouraged to join the lawsuit before December 31, 2024.
Portfolio Pulse from
November 13, 2024 | 3:45 pm
MEDP
Medpace Holdings, Inc. is under investigation by The Schall Law Firm for potential securities fraud. The investigation is centered on whether Medpace issued false or misleading statements or failed to disclose important information to investors.
Portfolio Pulse from
November 13, 2024 | 3:45 pm
CSX
CSX Corporation is under investigation by The Schall Law Firm for potential securities fraud, focusing on whether the company issued misleading statements or failed to disclose important information to investors.
Portfolio Pulse from
November 13, 2024 | 3:45 pm
WOLF
Levi & Korsinsky has initiated an investigation into Wolfspeed, Inc. for potential federal securities law violations. This follows an earnings call revealing slowed growth at its Mohawk Valley facility, indicating demand challenges.
Portfolio Pulse from
November 13, 2024 | 3:30 pm
IIPR
Levi & Korsinsky has initiated an investigation into Innovative Industrial Properties, Inc. (NYSE:IIPR) for potential violations of federal securities laws following the company's Q3 2024 financial results announcement.
Portfolio Pulse from
November 13, 2024 | 3:30 pm
JBI
Levi & Korsinsky has initiated an investigation into Janus International Group, Inc. (NYSE:JBI) for potential violations of federal securities laws following the company's recent financial results announcement.
Portfolio Pulse from
November 13, 2024 | 3:30 pm
XRX
Levi & Korsinsky has initiated an investigation into Xerox Holdings Corporation (XRX) for potential violations of federal securities laws following the company's Q3 2024 financial results announcement.
Portfolio Pulse from
November 13, 2024 | 3:30 pm
MYGN
Levi & Korsinsky has launched an investigation into Myriad Genetics, Inc. for potential violations of federal securities laws. This follows UnitedHealth Group's decision to stop covering Myriad's GeneSight test starting January 1, 2025.
Portfolio Pulse from
November 13, 2024 | 3:30 pm
TBBK
Levi & Korsinsky has initiated an investigation into The Bancorp, Inc. (NASDAQ:TBBK) for potential violations of federal securities laws following the company's Q3 2024 financial results announcement.
Portfolio Pulse from
November 13, 2024 | 3:30 pm
MQ
Levi & Korsinsky has initiated an investigation into Marqeta, Inc. for potential violations of federal securities laws after the company reduced its revenue growth forecast for Q4 2024.
Portfolio Pulse from
November 13, 2024 | 3:30 pm
Previous
Next